Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: Comparison of Ig/TCR rearrangements and the genomic fusion gene

Haematologica

Volumn 91, Issue 5, 2006, Pages 683-686

  Metzler, Markus ^a   Mann, Georg ^b   Monschein, Uli ^c   Lodzinski, Martin ^a   Gall, Christine ^a   Flohr, Thomas ^d   Viehmann, Susanne ^e   Langer, Thorsten ^a   Schrappe, Martin ^f   Gadner, Helmut ^c   Haas, Oskar A ^c   Panzer Grümayer, E Renate ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ETV6 RUNX1 fusion gene; Minimal residual disease; MRD; t(12; 21) ALL; TEL AML1

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILD; CHROMOSOME TRANSLOCATION 12; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; MINIMAL RESIDUAL DISEASE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CLONE CELLS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PRELEUKEMIA; PROGNOSIS; RECURRENCE; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 33744481524     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-48.
2. Cazzaniga G, Biondi A. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology. Haematologica 2005;90:382-90.
3. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
4. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003;3:639-49.
5. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999;35:173-85.
6. Ford AM, Fasching K, Panzer-Grumayer ER, Koenig M, Haas OA, Greaves MF. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood 2001;98:558-64.
7. Konrad M, Metzler M, Panzer S, Ostreicher I, Peham M, Repp R, et al. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 2003;101:3635-40.
8. Zuna J, Ford AM, Peham M, Patel N, Saha V, Eckert C, et al. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia. Clin Cancer Res 2004; 10:5355-60.
9. Peham M, Konrad M, Harbott J, Konig M, Haas OA, Panzer-Grumayer ER. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development. Genes Chromosomes Cancer 2004;39:156-60.
10. Schrappe M. Evolution of BFM trials for childhood ALL. Ann Hematol 2004;83 Suppl 1:5121-3.
11. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:110-8.
12. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003;17:1013-34.
13. Fronkova E, Madzo J, Zuna J, Reznickova L, Muzikova K, Hrusak O, et al. TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL. Leukemia 2005;19:1296-7.
14. van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998;352:1731-8.
15. Hubner S, Cazzaniga G, Flohr T, van der Velden VH, Konrad M, Potschger U, et al. High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias. Leukemia 2004;18:84-91.
16. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133-43.
17. Panzer-Grumayer ER, Cazzaniga G, van der Velden VH, del Giudice L, Peham M, Mann G, et al. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection. Clin Cancer Res 2005;11:7720-7.
18. Pine SR, Wiemels JL, Jayabose S, Sandoval C. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk Research 2003;27:155-64.